Lotus

Taipei, Taiwan Founded: 1966 • Age: 60 yrs Acquired By Innobic Asia
Contract manufacturing for oral solid formulations is offered.
Request Access

About Lotus

Lotus is a company based in Taipei (Taiwan) founded in 1966 was acquired by Innobic Asia in November 2021. It operates as a Direct-to-Consumer (D2C), and Reseller / Distribution. The company has 31 employees as of April 09, 2024. Lotus has completed 1 acquisition, including Alvogen. Lotus offers products and services including Oncology Products and Generic Pharmaceuticals. Lotus operates in a competitive market with competitors including Inventia Healthcare, Capsugel, Suzhou Ze Jing Biological Pharmaceutical, Zim Labs and Adare Pharma Solutions, among others.

  • Headquarter Taipei, Taiwan
  • Employees 31 as on 09 Apr, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Lotus Pharmaceutical Co., Ltd.
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
    $0 (USD)
    9.59
    as on Dec 31, 2024
  • Net Profit
    $0 (USD)
    23.38
    as on Dec 31, 2024
  • EBITDA
    $0 (USD)
    19.46
    as on Dec 31, 2024
  • Latest Funding Round
  • Investors
    Alvogen

    & 2 more

  • Employee Count
    31

    as on Apr 09, 2024

  • Investments & Acquisitions
  • Acquired by
    Innobic Asia

    & 1 more

    (Nov 26, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Lotus

Lotus is a publicly listed company on the TWSE with ticker symbol 1795 in Taiwan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: TWSE · Ticker: 1795 . Sector: Health technology · Taiwan

Products & Services of Lotus

Lotus offers a comprehensive portfolio of products and services, including Oncology Products and Generic Pharmaceuticals. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

High-quality oncology drugs are developed for global markets.

Affordable generic medicines are produced for various conditions.

People of Lotus
Headcount 50-200
Employee Profiles 43
Board Members and Advisors 7
Employee Profiles
People
Bharath Jayaraman
Head of SEA Markets
People
Petar Vazharov
CEO
People
Eeling Chan
CFO, Taiwan
People
Bjartur Shen
Strategies and Finance VP

Unlock access to complete

Board Members and Advisors
people
Jennifer Wang
Independent Director
people
Karl Karlsson
Independent Director
people
Yves Hermes
Board of Director
people
Phannalin Mahawongtikul
Board of Director

Unlock access to complete

Funding Insights of Lotus

  • Total Funding
  • Total Rounds 2
  • Last Round
  • First Round
  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2021 Amount Post-IPO - Lotus Valuation

investors

Apr, 2021 Amount Post-IPO - Lotus Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Lotus

Lotus has secured backing from 3 investors. Prominent investors backing the company include Alvogen, Aztiq and Innobic Asia. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Aztiq is engaged in investments within the pharmaceutical and biotech sectors.
Founded Year Domain Location
Pharmaceutical products are developed and marketed globally.
Founded Year Domain Location
Operates as a CDMO specializing in solid-based drug production.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Lotus

Lotus has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Alvogen. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Pharmaceutical products are developed and marketed globally.
2009
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Lotus

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Lotus Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Lotus

Lotus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inventia Healthcare, Capsugel, Suzhou Ze Jing Biological Pharmaceutical, Zim Labs and Adare Pharma Solutions, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Oral solid drug delivery systems are manufactured and developed.
domain founded_year HQ Location
Dosage forms are delivered for preclinical, clinical, and commercial supply.
domain founded_year HQ Location
Company developing small molecules & eukaryotic cell based recombinant protein drugs
domain founded_year HQ Location
Solid and semisolid dosage forms are developed and manufactured.
domain founded_year HQ Location
CDMO manufacturing solid drugs
domain founded_year HQ Location
Product development, manufacturing and packaging services
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Lotus

Frequently Asked Questions about Lotus

When was Lotus founded?

Lotus was founded in 1966 and raised its 1st funding round 55 years after it was founded.

Where is Lotus located?

Lotus is headquartered in Taipei, Taiwan.

Who is the current CEO of Lotus?

Robert Wessman is the current CEO of Lotus.

How many employees does Lotus have?

As of Apr 09, 2024, the latest employee count at Lotus is 31.

What does Lotus do?

Lotus is established as an international pharmaceutical entity with a focus on commercializing novel and generic drugs. Headquartered in Taiwan, the company is supported by a robust RD and manufacturing platform across Asia. A diverse portfolio of high-quality, affordable medicines is delivered to markets worldwide. Operations span oncology, generics, and contract research, with over 250 products in the market and more than 100 projects in development. Strategic partnerships and in-house capabilities are leveraged to maintain competitive speed and flexibility in the industry.

Who are the top competitors of Lotus?

Lotus's top competitors include Inventia Healthcare, Zim Labs and Contract Pharmacal Corp..

What products or services does Lotus offer?

Lotus offers Oncology Products and Generic Pharmaceuticals.

Is Lotus publicly traded?

Yes, Lotus is publicly traded on TWSE under the ticker symbol 1795.

How many acquisitions has Lotus made?

Lotus has made 1 acquisition, including Alvogen.

Who are Lotus's investors?

Lotus has 3 investors. Key investors include Alvogen, Aztiq, and Innobic Asia.

What is Lotus's ticker symbol?

The ticker symbol of Lotus is 1795 on TWSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available